(Information sent by the signatory company)
LANGHORNE, Pa., Feb. 5, 2024 /PRNewswire/ — Amplity Health, a leading global contract medical and commercial organization, today announced that it has appointed Chris Baker to the position of Chief Executive Officer, effective immediately. Michael A. Griffith, Amplity’s founder and longtime CEO, will transition to the role of Chairman of the Board of Directors as part of a deliberate succession plan. In this capacity, he will continue to support Baker and the leadership team, but with a primary focus on building visibility and awareness of Amplity in the biopharmaceutical market.
“Increasingly we see a convergence between medical engagement and business engagement,” Griffith said. “Chris brings significant leadership experience in large pharmaceutical commercial operations, contract research and data to this role. Her experience and growth trajectory are unique and make her an excellent fit for Amplity. I am delighted to introduce Chris as our new CEO and we look forward to supporting her as she works to accelerate our success.”
“Amplity is a high-quality medical and sales engine positioned exactly where the market is headed: the intersection where clinical, medical affairs and commercial biopharma teams are working tirelessly to accelerate and maximize the effectiveness of launch and access of patients to life-saving oncology, rare diseases and specialty medicines,” said Baker, who will also serve on Amplity’s board of directors.
“We have the best medical liaison and specialty sales talent to help drive adoption by physicians and patients,” he went on to say. “By maintaining our focus on the highest quality people and leveraging the right data to drive exceptional delivery, we will continue to expand our role as a trusted partner of choice for biopharmaceutical customers. I look forward to working with Mike, the Board and our talented team of leadership to achieve this vision.
According to Griffith, this transition comes at an exciting time in Amplity’s existence.
“Amplity currently has more than 90 medical and commercial programs under management in 41 countries, and entered 2024 with a 20% larger program pipeline year over year,” he said. “We have also strengthened our internal teams with the introduction of dynamic new leaders. I look forward to partnering with Chris and the team to build on this success, as we challenge our model to incorporate deeper, data-driven solutions.”
About Chris Baker
Baker joins Amplity from ICON plc, where she was most recently president of the Symphony Health division, a leading provider of high-value data, tokenization and technology solutions to healthcare companies. Previously, Baker was executive vice president and global head of Parexel’s FSP clinical outsourcing business. She was also a vice president at Pfizer, where she held leadership positions in sales and marketing, including conducting an expatriate tour in South Africa. Baker earned her MBA from the University of Chicago Booth School of Business and was a D1 volleyball player at Penn State University, where she earned her bachelor’s degree.
About Amplity
Amplity Health is a contract medical and commercial organization that employs more than 1,000 highly credentialed colleagues in 41 countries. Amplity delivers customized medical and commercial solutions that scale throughout a drug’s lifecycle. It is a global authority on scientific stakeholder engagement and commercialization strategies, and is built on a belief in the power of face-to-face interaction that builds trust with physicians, patients, and payers, and enables the sharing of complex ideas. At Amplity, our ambition is to operate at scale and behave like a boutique.
Contact:Gwen Coverdale267.884.6328Gwen.Coverdale@Amplity.com
Photo – https://mma.prnewswire.com/media/2334223…
Logo – https://mma.prnewswire.com/media/1937765…
View original content: https://www.prnewswire.com/news-releases/amplity-health-anuncia-cambios-de-liderazgo-302053657.html
